Results 51 to 60 of about 245,053 (402)

Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis

Circulation. Cardiovascular Interventions, 2020
Supplemental Digital Content is available in the text. Background: Large data comparing the performance of new-generation self-expandable versus balloon-expandable transcatheter heart valves in bicuspid aortic stenosis are lacking.
A. Mangieri, D. Tchétché, Won-Keun Kim, M. Pagnesi, J. Sinning, U. Landes, R. Kornowski, O. de Backer, G. Nickenig, A. Ielasi, Chiara De Biase, L. Søndergaard, F. De Marco, M. Montorfano, M. Chiarito, D. Regazzoli, G. Stefanini, P. Presbitero, S. Toggweiler, C. Tamburino, S. Immé, G. Tarantini, H. Sievert, U. Schäfer, J. Kempfert, Jochen Wöehrle, F. Gallo, A. Laricchia, A. Latib, Francesco Giannini, A. Colombo   +30 more
semanticscholar   +1 more source

Survival benefit of overweight patients undergoing MitraClip® procedure in comparison to normal‐weight patients

Clinical Cardiology, Volume 45, Issue 12, Page 1236-1245, December 2022., 2022
Long‐term survival stratified for weight classes illustrated by Hazard plot for patients treated with MitraClip® implantation stratified for weight classes. Association of weight class compared to normal‐weight with long‐term survival (adjusted for Logistic EuroScore).
Karsten Keller, Martin Geyer, Lukas Hobohm, Alexander R. Tamm, Felix Kreidel, Tobias F. Ruf, Michaela Hell, Volker H. Schmitt, Kevin Bachmann, Sonja Born, Eberhard Schulz, Thomas Münzel, Ralph S. von Bardeleben   +12 more
wiley   +1 more source

High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis [PDF]

, 2014
Aims: High-sensitivity cardiac troponin I (cTnI) assays hold promise in detecting the transition from hypertrophy to heart failure in aortic stenosis.
A. L. Hunter, A. Maria Choy, A. S. V. Shah, C. C. Lang, C. W. L. Chin, Cowell, D. A. McAllister, D. E. Newby, Dweck, Dweck, F. E. Strachan, J. P. Langrish, M. R. Dweck, Messroghli, Mills, N. A. Boon, N. L. Mills, Nkomo, Rosjo, S. Alam, S. Joanna Cowell, S. Walker, Thygesen, Wieczorek   +23 more
core   +4 more sources

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

New England Journal of Medicine, 2016
BACKGROUND Previous trials have shown that among high-risk patients with aortic stenosis, survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement. We evaluated the two procedures in a randomized
M. Leon, Craig R. Smith, M. Mack, M. Mack, R. Makkar, L. Svensson, S. Kodali, V. Thourani, M. Tuzcu, D. C. Miller, H. Herrmann, Darshan Doshi, D. Cohen, A. Pichard, S. Kapadia, T. Dewey, V. Babaliaros, W. Szeto, Mathew R. Williams, D. Kereiakes, A. Zajarías, K. Greason, B. Whisenant, R. Hodson, J. Moses, A. Trento, David L. Brown, W. Fearon, P. Pibarot, R. Hahn, W. Jaber, W. Anderson, Maria C. Alu, J. Webb   +33 more
semanticscholar   +1 more source

The brain‐before‐heart strategy for coronary artery bypass grafting in the severely atherosclerotic aorta: A single‐institution experience

Clinical Cardiology, Volume 45, Issue 12, Page 1264-1271, December 2022., 2022
Abstract Background Severe atherosclerosis of the ascending aorta (SAA) in patients undergoing surgical revascularization by coronary artery bypass grafting (CABG) is becoming an increasing problem as more elderly patients are diagnosed with coronary artery disease.
Rakan I. Nazer, Ali M. Albarrati
wiley   +1 more source

Aortic valve stenosis: Prognosis and therapy

Vojnosanitetski pregled, 2003
There is a long latent period in the clinical course of aortic valve stenosis in adults. Symptoms usually occur in the case of critical stenosis, when aortic orifice area is under 0.7cm2 (0.4 cm2/m2). In this study 78 patients with critical aortic valve stenosis were investigated. The first manifestation of the disease was dyspnea (78.2%), angina (52.5%
Milorad Damnjanović, Radomir Matunovic, Slobodan Obradovic, Jovanka Milovanović, Branko Gligic, Andelka Ristić-Andelkov   +5 more
openaire   +4 more sources

A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis

Arteriosclerosis, Thrombosis and Vascular Biology, 2020
Supplemental Digital Content is available in the text. Objective: Aortic valve (AV) calcification plays an important role in the progression of aortic stenosis (AS).
L. Matilla, C. Roncal, Jaime Ibarrola, V. Arrieta, A. García-Peña, A. Fernández-Celis, A. Navarro, V. Álvarez, A. Gainza, J. Orbe, V. Cachofeiro, G. Zalba, R. Sádaba, J. Rodríguez, N. López-Andrés   +14 more
semanticscholar   +1 more source

Predicting progression of aortic stenosis by measuring serum calcification propensity

Clinical Cardiology, Volume 45, Issue 12, Page 1297-1302, December 2022., 2022
Abstract Background The aim of this prospective, double‐blinded study in patients with aortic sclerosis was to determine whether a new calcification propensity measure in the serum could predict disease progression. Methods We included 129 consecutive patients with aortic sclerosis as assessed during a routine clinical echocardiographic exam. Clinical,
Reto Kurmann, Eric Buffle, Andreas Pasch, Christian Seiler, Stefano F. de Marchi   +4 more
wiley   +1 more source

Impact of Aortic Valve Replacement for Aortic Stenosis on Coexisting Mitral Stenosis

Annals of Thoracic and Cardiovascular Surgery, 2021
The course of coexisting mitral valve stenosis is not clear after aortic valve replacement (AVR) for aortic stenosis (AS). We investigated the effect of AVR for AS on coexisting mitral stenosis (MS).Between January 2002 and December 2019, 1338 consecutive patients underwent surgical AVR at Shiga University of Medical Science.
HACHIRO Kohei, KINOSHITA Takeshi, SUZUKI Tomoaki, ASAI Tohru   +3 more
openaire   +5 more sources

Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2020
Background Aortic valve replacement (AVR) is a life‐saving treatment for patients with symptomatic severe aortic valve stenosis. We sought to determine whether transcatheter AVR has resulted in a more equitable treatment rate by race in the United States.
J. M. Brennan, M. Leon, P. Sheridan, P. Sheridan, I. Boero, Qinyu Chen, Angela Lowenstern, V. Thourani, S. Vemulapalli, Kevin L. Thomas, Tracy Y. Wang, E. Peterson   +11 more
semanticscholar   +1 more source